Sectors & IndustriesFinancial ServicesInsurance - Specialty

Best Specialty Insurance Stocks to Buy Now (2026)

Top specialty insurance stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best specialty insurance stocks to buy now. Learn More.

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best specialty insurance stocks to buy right now are:

James River Group Holdings (NASDAQ:JRVR) is the #1 top specialty insurance stock out of 20 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for James River Group Holdings (NASDAQ:JRVR) is: Value: A, Growth: B, Momentum: C, Sentiment: C, Safety: C, Financials: C, and AI: C.

James River Group Holdings (NASDAQ:JRVR) has a Due Diligence Score of 30, which is -4 points lower than the specialty insurance industry average of 34. Although this number is below the industry average, our proven quant model rates JRVR as a "B".

JRVR passed 11 out of 38 due diligence checks and has average fundamentals. James River Group Holdings has seen its stock return 30.25% over the past year, overperforming other specialty insurance stocks by 31 percentage points.

James River Group Holdings has an average 1 year price target of $7.00, an upside of 12.9% from James River Group Holdings's current stock price of $6.20.

James River Group Holdings stock has a consensus Hold recommendation according to Wall Street analysts. Of the 2 analysts covering James River Group Holdings, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Enact Holdings (NASDAQ:ACT) is the #2 top specialty insurance stock out of 20 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for Enact Holdings (NASDAQ:ACT) is: Value: C, Growth: D, Momentum: C, Sentiment: B, Safety: C, Financials: C, and AI: C.

Enact Holdings (NASDAQ:ACT) has a Due Diligence Score of 44, which is 10 points higher than the specialty insurance industry average of 34.

ACT passed 16 out of 38 due diligence checks and has strong fundamentals. Enact Holdings has seen its stock return 19.39% over the past year, overperforming other specialty insurance stocks by 20 percentage points.

Enact Holdings has an average 1 year price target of $45.67, an upside of 6.87% from Enact Holdings's current stock price of $42.73.

Enact Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Enact Holdings, 33.33% have issued a Strong Buy rating, 0% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Trupanion (NASDAQ:TRUP) is the #3 top specialty insurance stock out of 20 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for Trupanion (NASDAQ:TRUP) is: Value: D, Growth: B, Momentum: D, Sentiment: C, Safety: C, Financials: C, and AI: C.

Trupanion (NASDAQ:TRUP) has a Due Diligence Score of 32, which is -2 points lower than the specialty insurance industry average of 34.

TRUP passed 10 out of 33 due diligence checks and has average fundamentals. Trupanion has seen its stock lose -34.45% over the past year, underperforming other specialty insurance stocks by -34 percentage points.

Trupanion has an average 1 year price target of $42.25, an upside of 76.12% from Trupanion's current stock price of $23.99.

Trupanion stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Trupanion, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 15 specialty insurance stocks that have issued dividends in the past year, the 3 specialty insurance stocks with the highest dividend yields are:

Amerisafe (NASDAQ:AMSF) has an annual dividend yield of 8.51%, which is 6 percentage points higher than the specialty insurance industry average of 2.38%. Amerisafe's dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Amerisafe's dividend has shown consistent growth over the last 10 years.

Amerisafe's dividend payout ratio of 105.7% indicates that its high dividend yield might not be sustainable for the long-term.

Investors Title Co (NASDAQ:ITIC) has an annual dividend yield of 4.46%, which is 2 percentage points higher than the specialty insurance industry average of 2.38%. Investors Title Co's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Investors Title Co's dividend has shown consistent growth over the last 10 years.

Investors Title Co's dividend payout ratio of 56.7% indicates that its high dividend yield is sustainable for the long-term.

Fidelity National Financial (NYSE:FNF) has an annual dividend yield of 3.9%, which is 2 percentage points higher than the specialty insurance industry average of 2.38%. Fidelity National Financial's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Fidelity National Financial's dividend has shown consistent growth over the last 10 years.

Fidelity National Financial's dividend payout ratio of 91% indicates that its high dividend yield might not be sustainable for the long-term.

Specialty insurance stocks were down -1.02% in the last day, and down -1.52% over the last week. Mgic Investment was the among the top losers in the insurance - specialty industry, dropping -9.1% yesterday.

MGIC Investment shares are trading lower after the company reported worse-than-expected Q1 sales results.

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued specialty insurance stocks right now are:

James River Group Holdings (NASDAQ:JRVR) is the most undervalued specialty insurance stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

James River Group Holdings has a valuation score of 71, which is 32 points higher than the specialty insurance industry average of 39. It passed 5 out of 7 valuation due diligence checks.

James River Group Holdings's stock has gained 30.25% in the past year. It has overperformed other stocks in the specialty insurance industry by 31 percentage points.

Axis Capital Holdings (NYSE:AXS) is the second most undervalued specialty insurance stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Axis Capital Holdings has a valuation score of 43, which is 4 points higher than the specialty insurance industry average of 39. It passed 3 out of 7 valuation due diligence checks.

Axis Capital Holdings's stock has gained 4.25% in the past year. It has overperformed other stocks in the specialty insurance industry by 5 percentage points.

Radian Group (NYSE:RDN) is the third most undervalued specialty insurance stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Radian Group has a valuation score of 71, which is 32 points higher than the specialty insurance industry average of 39. It passed 5 out of 7 valuation due diligence checks.

Radian Group's stock has gained 12.18% in the past year. It has overperformed other stocks in the specialty insurance industry by 13 percentage points.

58.82% of specialty insurance stocks rated by analysts are a buy right now. On average, analysts expect specialty insurance stocks to rise by 19.41% over the next year.

0% of specialty insurance stocks have a Zen Rating of A (Strong Buy), 5% of specialty insurance stocks are rated B (Buy), 75% are rated C (Hold), 15% are rated D (Sell), and 5% are rated F (Strong Sell).